Lithium Controlled-Release and Extended-Release Tablets and Vabomere (combination)
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Vabomere (combination) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: meropenem / vaborbactam
Brand name: Vabomere
Synonyms: Meropenem and vaborbactam, Meropenem and Vaborbactam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Vabomere Injection
- Lithium Controlled-Release and Extended-Release Tablets-Vaccinia
- Lithium Controlled-Release and Extended-Release Tablets-Vaccinia Immune Globulin (Intravenous)
- Lithium Controlled-Release and Extended-Release Tablets-Vaccinia immune globulin, human Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-VacuStim Black
- Lithium Controlled-Release and Extended-Release Tablets-VacuStim Wound Therapy Kit
- Vabomere (combination)-Lithium ER
- Vabomere (combination)-Lithium Oral Solution
- Vabomere (combination)-Lithium Salts
- Vabomere (combination)-Lithium Syrup and Oral Solution
- Vabomere (combination)-Lithobid
- Vabomere (combination)-Lithostat